Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001593968-17-000161
Filing Date
2017-01-26
Accepted
2017-01-26 17:54:31
Documents
1
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 3  
1 PRIMARY DOCUMENT primary_01.xml 3 1579
  Complete submission text file 0001593968-17-000161.txt   3060
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
McHugh Julie (Reporting) CIK: 0001487179 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36569 | Film No.: 17551154

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances